Literature DB >> 23406734

Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women.

W S Yang1, X O Shu, J Gao, H L Li, H Cai, G Yang, B T Ji, N Rothman, Y T Gao, W Zheng, Y B Xiang.   

Abstract

BACKGROUND: No prospective study has investigated the relationship between type 2 diabetes mellitus (T2DM) and the risk of primary liver cancer (PLC) in mainland China, and little is known about the effect of diabetes duration on PLC risk.
DESIGN: Data from two population-based cohorts (the Shanghai Men's Health Study, SMHS, 2002-2006 and the Shanghai Women's Health Study, SWHS, 1996-2000) were thus used to assess the associations among T2DM, diabetes duration and PLC risk in Chinese population.
RESULTS: During follow-up through 2009, 344 incident PLC cases were identified among 60 183 men and 73 105 women. T2DM is significantly associated with the increased risk of PLC in both men [hazard ratio (HR) = 1.63, 95% confidence interval (CI) 1.06-2.51] and women (HR = 1.64, 95% CI 1.03-2.61). The highest risk of incident liver cancer was observed in the first 5 years after diabetes diagnosis, and decreased substantially with the prolonged diabetes duration (P(trend) < 0.001). No synergistic interaction in the development of PLC was found between diabetes and other known risk factors.
CONCLUSIONS: T2DM is associated with the increased risk of subsequent liver cancer within 5 years after diagnosis in Chinese population, suggesting that hyperinsulinaemia rather than hyperglycaemia is more likely to be a primary mediator for this association.

Entities:  

Keywords:  China; cohort study; primary liver cancer; type 2 diabetes

Mesh:

Year:  2013        PMID: 23406734      PMCID: PMC3660077          DOI: 10.1093/annonc/mdt017

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  33 in total

1.  Validation of self-reported chronic conditions and health services in a managed care population.

Authors:  L M Martin; M Leff; N Calonge; C Garrett; D E Nelson
Journal:  Am J Prev Med       Date:  2000-04       Impact factor: 5.043

2.  The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan.

Authors:  S C Wu; C Y Li; D S Ke
Journal:  Public Health       Date:  2000-03       Impact factor: 2.427

3.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

4.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

5.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Authors:  Jian-Min Yuan; Sugantha Govindarajan; Kazuko Arakawa; Mimi C Yu
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

6.  Relationship of physical activity vs body mass index with type 2 diabetes in women.

Authors:  Amy R Weinstein; Howard D Sesso; I Min Lee; Nancy R Cook; JoAnn E Manson; Julie E Buring; J Michael Gaziano
Journal:  JAMA       Date:  2004-09-08       Impact factor: 56.272

7.  Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.

Authors:  K Saito; S Inoue; T Saito; S Kiso; N Ito; S Tamura; H Watanabe; H Takeda; H Misawa; H Togashi; Y Matsuzawa; S Kawata
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 8.  Nutrition, insulin, insulin-like growth factors and cancer.

Authors:  E Giovannucci
Journal:  Horm Metab Res       Date:  2003 Nov-Dec       Impact factor: 2.936

9.  Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

Authors:  Satheesh Nair; Andrew Mason; James Eason; George Loss; Robert P Perrillo
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

10.  Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.

Authors:  Manal M Hassan; Lu-Yu Hwang; Chiq J Hatten; Mark Swaim; Donghui Li; James L Abbruzzese; Palmer Beasley; Yehuda Z Patt
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

View more
  21 in total

1.  Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults.

Authors:  Peter T Campbell; Christina C Newton; Neal D Freedman; Jill Koshiol; Michael C Alavanja; Laura E Beane Freeman; Julie E Buring; Andrew T Chan; Dawn Q Chong; Mridul Datta; Mia M Gaudet; J Michael Gaziano; Edward L Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lindsey King; I-Min Lee; Martha S Linet; Julie R Palmer; Jessica L Petrick; Jenny N Poynter; Mark P Purdue; Kim Robien; Lynn Rosenberg; Vikrant V Sahasrabuddhe; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Victoria L Stevens; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Andrew G Renehan; Katherine A McGlynn
Journal:  Cancer Res       Date:  2016-10-15       Impact factor: 12.701

2.  Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.

Authors:  Neehar D Parikh; Sherry Fu; Huiying Rao; Ming Yang; Yumeng Li; Corey Powell; Elizabeth Wu; Andy Lin; Baocai Xing; Lai Wei; Anna S F Lok
Journal:  Dig Dis Sci       Date:  2017-09-25       Impact factor: 3.199

3.  Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women.

Authors:  Xiao Luo; Jing Sui; Wanshui Yang; Qi Sun; Yanan Ma; Tracey G Simon; Geyu Liang; Jeffrey A Meyerhardt; Andrew T Chan; Edward L Giovannucci; Xuehong Zhang
Journal:  Am J Gastroenterol       Date:  2019-12       Impact factor: 10.864

4.  Type 2 diabetes and the risk of non-Hodgkin's lymphoma: a report from two population-based cohort studies in China.

Authors:  Wan-Shui Yang; Hong-Lan Li; Hong-Li Xu; Gong Yang; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Eur J Cancer Prev       Date:  2016-03       Impact factor: 2.497

5.  Association of Inflammatory and Insulinemic Potential of Diet and Lifestyle with Risk of Hepatocellular Carcinoma.

Authors:  Wanshui Yang; Jing Sui; Longgang Zhao; Yanan Ma; Fred K Tabung; Tracey G Simon; Dong Hoon Lee; Xufen Zeng; Long H Nguyen; Jeffrey A Meyerhardt; Andrew T Chan; Edward L Giovannucci; Xuehong Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-01-29       Impact factor: 4.090

6.  Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China.

Authors:  Meng Wang; Ru-Ying Hu; Hai-Bin Wu; Jin Pan; Wei-Wei Gong; Li-Hua Guo; Jie-Ming Zhong; Fang-Rong Fei; Min Yu
Journal:  Sci Rep       Date:  2015-06-17       Impact factor: 4.379

7.  Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.

Authors:  Yan-Yan Wang; Shan Huang; Jian-Hong Zhong; Yang Ke; Zhe Guo; Jia-Qi Liu; Liang Ma; Hang Li; Bing-Ning Ou; Le-Qun Li
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

8.  Population-based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women.

Authors:  Hong-Li Xu; Yu-Ting Tan; Meira Epplein; Hong-Lan Li; Jing Gao; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Cancer Sci       Date:  2015-01-28       Impact factor: 6.716

9.  Incidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, China.

Authors:  Yunjuan Gu; Xuhong Hou; Ying Zheng; Chunfang Wang; Lei Zhang; Jie Li; Zhezhou Huang; Ming Han; Yuqian Bao; Weijian Zhong; Weiping Jia; Shiwei Cui
Journal:  Int J Environ Res Public Health       Date:  2016-06-03       Impact factor: 3.390

10.  Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai.

Authors:  Wan-Shui Yang; Yang Yang; Gong Yang; Wong-Ho Chow; Hong-Lan Li; Yu-Tang Gao; Bu-Tian Ji; Nat Rothman; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.